Feasibility study demonstrates MRI cytometry can effectively assess RCC grade, suggesting reduced reliance on invasive biopsies.
Motivation: Renal cell carcinoma (RCC) grading is essential for prognosis and treatment planning but currently relies on invasive biopsies, which have limitations and risks. Goal(s): Develop a non-invasive imaging technique to accurately assess RCC grade. Approach: We used IMPULSED, a type of MRI cytometry imaging method to measure average cell sizes in human RCC samples, and correlated these with histological tumor grade. A feasibility study was conducted on a subject with kidney cancer using a clinical 3T scanner to validate clinical applicability. Results: MRI-derived cell size estimates decreased with increasing RCC grade, aligning with histopathological features of tumor aggressiveness. Impact: This technique could reduce biopsies and improve RCC diagnosis, grading, and treatment decisions.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: